Gene · 1366
Papers1,866
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,866
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Persisting Shadows: Unraveling the Impact of Long COVID-19 on Respiratory, Cardiovascular, and Nervous Systems. | Infect Dis Rep | 2023 | 38131885 | PubTator, text mining | PubMed |
| An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancer. | Front Immunol | 2023 | 38124743 | PubTator, text mining | PubMed |
| Expression Profiles of Genes Related to Development and Progression of Endometriosis and Their Association with Paraben and Benzophenone Exposure. | Int J Mol Sci | 2023 | 38069001 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance. | Cancers (Basel) | 2023 | 38067255 | PubTator, text mining | PubMed |
| Myrrh protects against IL-13-induced epithelial barrier breakdown in HT-29/B6 cells. | Front Pharmacol | 2023 | 38044939 | PubTator, text mining | PubMed |
| Advances in paper-based electrochemical immunosensors: review of fabrication strategies and biomedical applications. | R Soc Open Sci | 2023 | 38034121 | PubTator, text mining | PubMed |
| Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers. | Front Immunol | 2023 | 38022574 | PubTator, text mining | PubMed |
| Influences of Yogurt with Functional Ingredients from Various Sources That Help Treat Leaky Gut on Intestinal Barrier Dysfunction in Caco-2 Cells. | Pharmaceuticals (Basel) | 2023 | 38004377 | PubTator, text mining | PubMed |
| Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective. | Cancers (Basel) | 2023 | 38001653 | PubTator, text mining | PubMed |
| Role of Stress on Driving the Intestinal Paracellular Permeability. | Curr Issues Mol Biol | 2023 | 37998758 | PubTator, text mining | PubMed |
| Tight Junction Claudins and Occludin Are Differentially Regulated and Expressed in Genomically Defined Subsets of Colon Cancer. | Curr Issues Mol Biol | 2023 | 37998722 | PubTator, text mining | PubMed |
| Are the Cutaneous Microbiota a Guardian of the Skin's Physical Barrier? The Intricate Relationship between Skin Microbes and Barrier Integrity. | Int J Mol Sci | 2023 | 37958945 | PubTator, text mining | PubMed |
| Epithelial Barrier Theory: The Role of Exposome, Microbiome, and Barrier Function in Allergic Diseases. | Allergy Asthma Immunol Res | 2023 | 37957791 | PubTator, text mining | PubMed |
| Expression patterns of claudins in cancer. | Heliyon | 2023 | 37954388 | PubTator, text mining | PubMed |
| Profiling of the fecal microbiota and circulating microRNA-16 in IBS subjects with Blastocystis infection : a case-control study. | Eur J Med Res | 2023 | 37932792 | PubTator, text mining | PubMed |
| A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data. | Heliyon | 2023 | 37920509 | PubTator, text mining | PubMed |
| Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease. | Fluids Barriers CNS | 2023 | 37907966 | PubTator, text mining | PubMed |
| Research progress of Claudin-low breast cancer. | Front Oncol | 2023 | 37904877 | PubTator, text mining | PubMed |
| Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms. | Cells | 2023 | 37887317 | PubTator, text mining | PubMed |
| Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics. | Biosensors (Basel) | 2023 | 37887119 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1366/papers?page=6